A pivotal role for galectin-1 in fetomaternal tolerance

SM Blois, JM Ilarregui, M Tometten, M Garcia… - Nature medicine, 2007 - nature.com
SM Blois, JM Ilarregui, M Tometten, M Garcia, AS Orsal, R Cordo-Russo, MA Toscano…
Nature medicine, 2007nature.com
A successful pregnancy requires synchronized adaptation of maternal immune-endocrine
mechanisms to the fetus. Here we show that galectin-1 (Gal-1), an immunoregulatory glycan-
binding protein, has a pivotal role in conferring fetomaternal tolerance. Consistently with a
marked decrease in Gal-1 expression during failing pregnancies, Gal-1–deficient
(Lgals1−/−) mice showed higher rates of fetal loss compared to wild-type mice in allogeneic
matings, whereas fetal survival was unaffected in syngeneic matings. Treatment with …
Abstract
A successful pregnancy requires synchronized adaptation of maternal immune-endocrine mechanisms to the fetus. Here we show that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance. Consistently with a marked decrease in Gal-1 expression during failing pregnancies, Gal-1–deficient (Lgals1−/−) mice showed higher rates of fetal loss compared to wild-type mice in allogeneic matings, whereas fetal survival was unaffected in syngeneic matings. Treatment with recombinant Gal-1 prevented fetal loss and restored tolerance through multiple mechanisms, including the induction of tolerogenic dendritic cells, which in turn promoted the expansion of interleukin-10 (IL-10)–secreting regulatory T cells in vivo. Accordingly, Gal-1's protective effects were abrogated in mice depleted of regulatory T cells or deficient in IL-10. In addition, we provide evidence for synergy between Gal-1 and progesterone in the maintenance of pregnancy. Thus, Gal-1 is a pivotal regulator of fetomaternal tolerance that has potential therapeutic implications in threatened pregnancies.
nature.com